Skip to content

Effects of Alpha Lipoic Acid Supplementation in G6PD Deficient Individuals After Acute Exercise

Effects of Alpha Lipoic Acid Supplementation in G6PD Deficient Individuals After Acute Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02937363
Enrollment
10
Registered
2016-10-18
Start date
2016-12-31
Completion date
2017-07-31
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G6PD Deficiency

Brief summary

The purpose of this study is to investigate the effects of alpha-lipoic acid supplementation on redox status, physiological and biochemical parameters in G6PD deficient individuals after acute exercise.

Detailed description

In a randomized double-blind, crossover design, 12 adult volunteers with G6PD deficiency of both sexes will be supplemented with either 600 mg of alpha-lipoic acid (experimental condition - EC) or placebo (control condition - CC) every day for 4 weeks. Before intervention, all participants will be informed about the study protocol, fill a medical history questionnaire and sign an informed consent form. Moreover, measurements of anthropometric characteristics and physiological parameters, as well as a VO2max test will be performed. Participants will perform 4 trials of exercise (70% VO2max for 45min and 90% till exhaustion) before and after each condition. Blood samples will be collected before, immediately after and 1 hour after exercise. Moreover, measurements of anthropometric characteristics and physiological parameters will be performed before and after each condition. There will be a washout period of at 4 weeks between conditions.

Interventions

DIETARY_SUPPLEMENTAlpha-lipoic acid

A trial of exercise before and after 4 weeks of alpha-lipoic acid supplementation.

OTHERPlacebo

A trial of exercise before and after 4 weeks of placebo administration.

Sponsors

University of Thessaly
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* G6PD deficiency

Exclusion criteria

* Any uncontrolled health condition for which exercise is contraindicated * Current use of dietary supplements or drugs * Pregnant, pregnancy intention or breast feeding

Design outcomes

Primary

MeasureTime frameDescription
Change in redox status after exerciseBefore, immediately after and 1 hour after each trial of exerciseIndices of blood redox status

Secondary

MeasureTime frameDescription
Body compositionBefore and after 4 weeks of alpha-lipoic acid supplementation, before and after 4 weeks of placeboBody fat percentage
Blood pressureBefore and after 4 weeks of alpha-lipoic acid supplementation, before and after 4 weeks of placeboBlood pressure at rest

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026